Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.150
-0.080 (-3.59%)
At close: Sep 8, 2026, 4:00 PM EDT
2.190
-0.040 (-1.79%)
After-hours: Sep 8, 2026, 7:59 PM EDT
Intelligent Bio Solutions Employees
As of June 30, 2026, Intelligent Bio Solutions had 60 total employees, including 59 full-time and 1 part-time employees. The number of employees increased by 5 or 9.09% compared to the previous year.
Employees
60
Change (1Y)
5
Growth (1Y)
9.09%
Revenue / Employee
$70,253
Profits / Employee
-$207,183
Market Cap
6.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 60 | 5 | 9.09% | 59 | 1 |
| Jun 30, 2025 | 55 | 5 | 10.00% | 53 | 2 |
| Jun 30, 2024 | 50 | -1 | -1.96% | 50 | 0 |
| Jun 30, 2023 | 51 | 39 | 325.00% | 51 | 0 |
| Jun 30, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| WORK Medical Technology Group LTD | 238 |
| Co-Diagnostics | 115 |
| Picard Medical | 75 |
| IceCure Medical | 69 |
| VolitionRx | 57 |
| Biomerica | 54 |
| INVO Fertility | 42 |
INBS News
- 7 days ago - Intelligent Bio Solutions announces private placement of up to $15M - TheFly
- 7 days ago - Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - GlobeNewsWire
- 7 days ago - Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 11 days ago - Intelligent Bio Solutions Slides: Investor presentation - Filings
- 20 days ago - Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth - GlobeNewsWire
- 21 days ago - Intelligent Bio Solutions Annual report: Q4 2026 - Filings
- 21 days ago - Intelligent Bio Solutions Earnings release: Q4 2026 - Filings
- 22 days ago - Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - GlobeNewsWire